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Abstract
Introduction: Nerve sheath tumours of the kidney are particularly rare and, in the few reported
cases, are all situated in the hilar region.
Case presentation: We describe the case of a tumour presenting towards the lateral border of
the ventral aspect of the mid-zone of the kidney. This was a spindle cell lesion in which the cells
strongly and diffusely expressed cytokeratins, but were negative for epithelial membrane antigen.
The cells also expressed S-100 protein and glial fibrillary acidic protein, confirming the diagnosis of
a cellular schwannoma.
Conclusion: To the best of our knowledge, this is the first case of a cellular schwannoma
presenting towards the lateral border of the kidney. The case also highlights the importance of
using a panel of antibodies in diagnosing spindle cell neoplasms in the kidney.
Introduction
Schwannomas are encapsulated nerve sheath tumours
that occur at all ages, but are most common between the
ages of 20 and 50 years and affect both genders equally.
The tumours have a predilection for the head, neck and
flexor surfaces of the upper and lower extremities. Deeply
situated tumours predominate in the posterior mediasti-
num and the retroperitoneum [1]. A schwannoma is a
slowly growing tumour that is usually present several
years before diagnosis. Schwannomas behave in a benign
fashion and malignant change is rare [2,3].
Case presentation
A 55-year-old man presented with lower urinary tract
symptoms in the form of hesitancy, poor stream and
urgency. The patient did not have any flank and/or colicky
pain. He had no history of urinary tract-related diseases or
previous related illnesses and was constitutionally well
with good appetite and normal body mass index. No
abnormalities were detected on clinical examination.
Laboratory investigations revealed that serum prostate
specific antigen was 5.1 ng/ml and serum creatinine was
86 μmol/l. Urine microscopy revealed no atypical cells
and no haematuria. Prostate core biopsies showed benign
prostatic hyperplasia.
An incidental exophytic lesion measuring 3 × 3.2 × 4.2 cm
was discovered in the right kidney on abdominal ultra-
sound. This was a homogeneous hypoechoic structure
with a well-defined margin seen lying towards the lateral
border of the ventral aspect of the mid-zone of the kidney.
The lesion appeared as a soft tissue abnormality on con-
trast renal computed tomography (Figure 1). There was a
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small area of calcification within it. The maximum diam-
eter was approximately 2.17 cm.
The lesion was removed by laparoscopic partial nephrec-
tomy with a small amount of renal parenchyma and sur-
rounding fat with clear surgical margins as a curative
approach. The specimen comprised a nodule surrounded
by fat and attached with a small pedicle to a piece of renal
tissue. The nodule was well-circumscribed, seemingly
encapsulated, firm in consistency and measured 2.5 × 1.4
× 2.5 cm. The cut surface was grey-white with microcystic
areas.
Microscopic examination showed a well-circumscribed,
partially encapsulated spindle cell lesion. The spindle cells
were arranged in whorls and intersecting fascicles with
focal intervening sclerosis. The tumour displayed rela-
tively uniform cellularity. No cytological atypia, necrosis
or mitoses were present. Thick-walled, hyalinised blood
vessels and aggregates of foamy macrophages were
present (Figure 2A–D). A cuff of lymphoid tissue sur-
rounded the tumour.
Immunostaining for a panel of cytokeratins was per-
formed including broad range cytokeratins (AE1/AE3)
and CK 7. The cells strongly and diffusely expressed cytok-
eratins on using a broad range cytokeratin cocktail, but
were negative for CK7. The cells were also negative for epi-
thelial membrane antigen (EMA). The tumour cells
expressed S-100 protein and glial fibrillary acidic protein
(GFAP) and were negative for HMB45, melan A, smooth
muscle actin (SMA), desmin, CD34 and CD117. Immu-
nostaining for Ki67 showed a very low index of less than
1% (Figure 2E–I).
The morphology and immunoprofile were characteristic
of a cellular schwannoma.
Discussion
A schwannoma is a benign nerve sheath tumour consist-
ing of a highly ordered cellular component (Antoni A
areas) and a loose myxoid component (Antoni B areas).
Antoni A areas are composed of compact spindle cells that
usually have wavy nuclei and indistinct cytoplasmic bor-
ders. The cells are arranged in interlacing fascicles and
short bundles. In highly differentiated Antoni A areas,
there may be nuclear palisading, whorling of the cells and
Verocay bodies, formed by two compact rows of well-
aligned nuclei separated by fibrillary cell processes. In
Antoni B areas, the cells are arranged haphazardly in a
loose matrix.
Cellular schwannoma is a rare variant of schwannomas,
composed almost entirely of Antoni A areas that lack
Verocay bodies. Small amounts of Antoni B may be
present, usually not exceeding 10% of the lesion [4].
Underneath their capsule they may contain lymphoid
aggregates. Cellular schwannoma occurs in a similar age
group as classic schwannoma but tends to develop more
often in deep structures, such as the posterior mediasti-
num and retroperitoneum. Initial scepticism was
expressed about the biological behaviour of cellular
schwannomas, with some suggesting that it was in fact a
low-grade malignant peripheral nerve sheath tumour
(MPNST). Woodruff et al. [5] stressed the benign clinical
course of cellular schwannomas and the importance of
distinguishing them from MPNST. Subsequent studies
have confirmed the benign nature of this tumour [6,7].
Nerve sheath tumours of the kidney seem to be particu-
larly rare, with only eight cases reported in the literature
[8-10]. The renal hilum is a common site of renal schwan-
noma [11-13].
We have reported the case of a renal schwannoma. To the
best of the authors' knowledge, this is the first case of a
schwannoma reported towards the lateral border of the
kidney rather than in the hilar region. On microscopic
examination, this was a cellular schwannoma and hence
did not show the typical features of a classical schwan-
noma, including the Antoni A and Antoni B areas. On
immunostaining, the cells showed diffuse and strong pos-
itivity for cytokeratins. Focal cytokeratin expression has
been reported in schwannomas [14], but in this case, the
cytokeratin expression using a broad range cytokeratin
cocktail was strong and seen in all cells. However, the cells
were all negative for cytokeratin 7 and EMA. The strong
A computed tomography scan showing a right renal mass  present on the ventral aspect of the kidney away from the  hilar region (arrow) Figure 1
A computed tomography scan showing a right renal 
mass present on the ventral aspect of the kidney 
away from the hilar region (arrow).
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Histological features of a schwannoma Figure 2
Histological features of a schwannoma. This is a spindle cell lesion surrounded by a rim of lymphocytes (A), ×100. The 
lesion is composed of fascicles of bland spindle cells (B), magnification ×600. There are aggregates of foamy histiocytes (C), 
magnification ×400. Thick-walled blood vessels are focally present (D), magnification ×200. The cells express S-100 protein (E), 
glial fibrillary acidic protein (F), magnification ×100; are negative for CK7 (G), magnification ×200; but express broad range 
cytokeratins (H), magnification ×100. The Ki67 index is very low, less than 1% (I), magnification ×400.Journal of Medical Case Reports 2008, 2:189 http://www.jmedicalcasereports.com/content/2/1/189
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cytokeratin expression with the atypical histological fea-
tures could have led to a diagnosis of an epithelial renal
neoplasm as a sarcomatoid carcinoma.
S-100 protein has been shown to have a broad distribu-
tion in human tissues, including the renal tubules. Lin et
al. [15] studied the expression of S-100 protein in primary
and metastatic renal cell carcinoma (RCC) and non-neo-
plastic renal tissue. The results demonstrated the nuclear
and cytoplasmic staining pattern for S-100 protein in 56
(69%) out of 81 conventional (clear cell) RCCs, 10 (30%)
out of 33 papillary RCCs, 1 (6%) out of 16 chromophobe
RCCs, and 13 (87%) out of 15 oncocytomas. Focal immu-
nostaining was present in 22 (92%) out of 24 normal
renal tubules. A similar staining pattern was observed in
21 (70%) out of 30 metastatic RCCs. Importantly, 14.8%
(12 out of 81) of clear cell RCC and 13.3% (4 out of 30)
of metastatic RCC revealed an immunostaining profile of
pancytokeratin (-)/S-100 protein (+). These data indicate
that caution should be taken in interpreting an unknown
primary with S-100 positivity and cytokeratin negativity
[15]. This highlights the importance of using a panel of
antibodies on handling a spindle cell lesion of the kidney
to cover all of the possible differential diagnoses such as
sarcomatoid carcinoma and synovial sarcoma in the con-
text of the gross and histological features.
Different markers were used to exclude other spindle cell
lesions. The markers for smooth muscle differentiation,
desmin and SMA, were negative. Melan A and HMB45
were negative excluding a melanocytic lesion or an angi-
omyolipoma. CD34 and CD117 were used to exclude a
gastrointestinal stromal tumour, whereas GFAP expres-
sion confirmed neural differentiation.
The patient presented with lower urinary tract symptoms,
which were caused by benign prostatic hyperplasia, and
the symptoms were not related to the renal neoplasm. The
renal tumour was an incidental finding during routine
investigations. There were no symptoms attributable to
the lesion, which was completely asymptomatic. No flank
pain and/or colic was ever experienced by the patient, and
urine analysis did not show haematuria or atypical cells.
The patient was constitutionally well, with a good appe-
tite and normal body mass index and did not report any
recent weight loss.
The differential diagnosis included RCC, therefore a cura-
tive approach was taken with laparoscopic partial
nephrectomy including renal parenchyma with clear sur-
gical margins.
A dimercaptosuccinic acid renal scan follow-up showed a
differential renal function of 49% in the right kidney.
Three years after the removal of the tumour the patient is
well.
To the best of our knowledge, this is the first case of a renal
schwannoma presenting towards the lateral border of the
kidney. This was a cellular schwannoma, which showed,
in addition to the expression of S-100 protein and GFAP,
strong and diffuse expression of cytokeratins.
Conclusion
Renal schwannomas, although rare, must be considered
in the differential diagnosis of spindle cell lesions of the
kidney. We report a case of an incidentally identified per-
irenal schwannoma, which was treated by partial nephrec-
tomy. In 1988, Somers et al. [9] reported a case of renal
schwannoma recommending radical nephrectomy as the
treatment of choice as then very few cases had been
reported and the natural history and potential for malig-
nancy was uncertain. Now given the benign clinical
course of schwannomas, nephron-sparing surgery seems
to be appropriate if technically feasible and the diagnosis
is considered pre-operatively.
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